Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients With Stage IV Malignant Melanoma Without Prior Treatment: A Phase IIa Trial

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-2663
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Phase II Trial of Karenitecin in Patients With Malignant Melanoma: Clinical and Translational Study

Clinical Cancer Research
Cancer ResearchOncology
2005English

Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

Safety and Efficacy of PDpoetin for Management of Anemia in Patients With End Stage Renal Disease on Maintenance Hemodialysis: Results From a Phase IV Clinical Trial

Hematology Reports
Hematology
2014English

Recombinant Human Interleukin 6 in Metastatic Renal Cell Cancer: A Phase II Trial

British Journal of Cancer
Cancer ResearchOncology
1996English

Flavone Acetic Acid (FAA) With Recombinant Interleukin-2 (rIL-2) in Advanced Malignant Melanoma: I. Clinical and Vascular Studies

British Journal of Cancer
Cancer ResearchOncology
1993English

Treatment of Uveitis With Recombinant Human Interleukin-13

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1998English

A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma

Oncologist
Cancer ResearchMedicineOncology
2015English

Vaccination With LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients--Report of a Phase I/IIa Clinical Trial

Clinical Cancer Research
Cancer ResearchOncology
2015English

Recombinant Human Interleukin 2 Treatment in Patients With Chronic Hepatitis B Virus Infection.

Japanese Journal of Clinical Immunology
1989English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy